From February 7, 2024 to March 31, 2024, the company has repurchased 2,718,010 shares, representing 3.04% for CNY 87.02 million. With this, the company has completed the repurchase of 2,718,010 shares, representing 3.04% for CNY 87.02 million under the buyback announced on February 8, 2024.
Beijing Hotgen Biotech Co., Ltd.
Equities
688068
CNE100003P82
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.55 CNY | -1.50% | -8.66% | -28.01% |
29/04 | Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/04 | Beijing Hotgen Biotech to Buy Kaijing Gene Technology for 11 Million Yuan | MT |
1st Jan change | Capi. | |
---|---|---|
-28.01% | 37Cr | |
-4.98% | 18TCr | |
+2.84% | 11TCr | |
-2.68% | 6.86TCr | |
+4.53% | 5.16TCr | |
+8.00% | 4.42TCr | |
+9.65% | 4.36TCr | |
+25.30% | 3.25TCr | |
-0.17% | 2.56TCr | |
+21.57% | 2.6TCr |
- Stock Market
- Equities
- 688068 Stock
- News Beijing Hotgen Biotech Co., Ltd.
- Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2024.